Annual Accounts Payable
$1.70 M
+$1.28 M+305.19%
31 December 2023
Summary:
ProQR Therapeutics NV annual accounts payable is currently $1.70 million, with the most recent change of +$1.28 million (+305.19%) on 31 December 2023. During the last 3 years, it has risen by +$1.43 million (+526.71%). PRQR annual accounts payable is now at all-time high.PRQR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$34.60 K
-$800.00-2.26%
01 September 2024
Summary:
ProQR Therapeutics NV quarterly accounts payable is currently $34.60 thousand, with the most recent change of -$800.00 (-2.26%) on 01 September 2024. Over the past year, it has dropped by -$89.20 thousand (-72.05%). PRQR quarterly accounts payable is now -98.68% below its all-time high of $2.61 million, reached on 31 March 2015.PRQR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRQR Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +305.2% | -72.0% |
| 3 y3 years | +526.7% | -96.7% |
| 5 y5 years | +1003.2% | -95.3% |
PRQR Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +687.5% | -98.0% | at low |
| 5 y | 5 years | at high | +1003.2% | -98.0% | at low |
| alltime | all time | at high | +1256.2% | -98.7% | at low |
ProQR Therapeutics NV Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.60 K(-2.3%) |
| June 2024 | - | $35.40 K(-90.1%) |
| Mar 2024 | - | $357.40 K(-79.0%) |
| Dec 2023 | $1.70 M(+305.2%) | $1.70 M(+1275.9%) |
| Sept 2023 | - | $123.80 K(-4.3%) |
| June 2023 | - | $129.30 K(-57.0%) |
| Mar 2023 | - | $301.00 K(-28.4%) |
| Dec 2022 | $420.40 K(+94.4%) | $420.40 K(+0.6%) |
| Sept 2022 | - | $417.70 K(-47.9%) |
| June 2022 | - | $801.20 K(-12.9%) |
| Mar 2022 | - | $919.70 K(+325.2%) |
| Dec 2021 | $216.30 K(-20.4%) | $216.30 K(-79.1%) |
| Sept 2021 | - | $1.04 M(+215.8%) |
| June 2021 | - | $328.40 K(+1.9%) |
| Mar 2021 | - | $322.40 K(+18.6%) |
| Dec 2020 | $271.80 K(-45.5%) | $271.80 K(-20.4%) |
| Sept 2020 | - | $341.60 K(-38.3%) |
| June 2020 | - | $553.30 K(-13.2%) |
| Mar 2020 | - | $637.50 K(+27.9%) |
| Dec 2019 | $498.50 K | $498.50 K(-31.8%) |
| Sept 2019 | - | $730.90 K(+241.9%) |
| June 2019 | - | $213.80 K(+197.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $71.90 K(-53.4%) |
| Dec 2018 | $154.40 K(-76.4%) | $154.40 K(-82.8%) |
| Sept 2018 | - | $895.90 K(+253.8%) |
| June 2018 | - | $253.20 K(+39.7%) |
| Mar 2018 | - | $181.20 K(-72.3%) |
| Dec 2017 | $655.00 K(+88.9%) | $655.00 K(+122.4%) |
| Sept 2017 | - | $294.50 K(+14.9%) |
| June 2017 | - | $256.20 K(+35.5%) |
| Mar 2017 | - | $189.10 K(-45.5%) |
| Dec 2016 | $346.70 K(-64.2%) | $346.70 K(+30.4%) |
| Sept 2016 | - | $265.90 K(-77.0%) |
| June 2016 | - | $1.15 M(-0.7%) |
| Mar 2016 | - | $1.16 M(+20.2%) |
| Dec 2015 | $967.60 K(-36.2%) | $967.60 K(+777.2%) |
| Sept 2015 | - | $110.30 K(-89.0%) |
| June 2015 | - | $1.00 M(-61.7%) |
| Mar 2015 | - | $2.61 M(+72.3%) |
| Dec 2014 | $1.52 M(+47.4%) | $1.52 M(+8.3%) |
| Sept 2014 | - | $1.40 M(+15.8%) |
| June 2014 | - | $1.21 M(+17.5%) |
| Dec 2013 | $1.03 M(+719.0%) | $1.03 M |
| Dec 2012 | $125.60 K | - |
FAQ
- What is ProQR Therapeutics NV annual accounts payable?
- What is the all time high annual accounts payable for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual accounts payable year-on-year change?
- What is ProQR Therapeutics NV quarterly accounts payable?
- What is the all time high quarterly accounts payable for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly accounts payable year-on-year change?
What is ProQR Therapeutics NV annual accounts payable?
The current annual accounts payable of PRQR is $1.70 M
What is the all time high annual accounts payable for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual accounts payable is $1.70 M
What is ProQR Therapeutics NV annual accounts payable year-on-year change?
Over the past year, PRQR annual accounts payable has changed by +$1.28 M (+305.19%)
What is ProQR Therapeutics NV quarterly accounts payable?
The current quarterly accounts payable of PRQR is $34.60 K
What is the all time high quarterly accounts payable for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly accounts payable is $2.61 M
What is ProQR Therapeutics NV quarterly accounts payable year-on-year change?
Over the past year, PRQR quarterly accounts payable has changed by -$89.20 K (-72.05%)